The largest database of trusted experimental protocols

Anti siglec f antibody

Manufactured by R&D Systems

The Anti-Siglec F antibody is a laboratory research tool designed to detect the Siglec-F protein, which is expressed on the surface of mouse eosinophils. This antibody can be used in applications such as flow cytometry and immunohistochemistry to identify and study eosinophils in mouse models.

Automatically generated - may contain errors

2 protocols using anti siglec f antibody

1

Zymosan-Induced Inflammatory Pain Model

Check if the same lab product or an alternative is used in the 5 most similar protocols
Male C57BL/6N mice (6–8 weeks) were purchased from Janvier (Le Genest, France) and treated according to the International Association for the Study of Pain guidelines. For all experiments the ethics guidelines for investigations in conscious animals were obeyed and the procedures were approved by the local ethics committee (Regierungspräsidium Darmstadt). The animals had free access to food and water and were maintained in climate‐ (23 ± 0.5°C) and light‐controlled rooms (light from 6.00 a.m. to 6.00 p.m.).
Inflammation was induced by injection of 10 μl zymosan (3 mg/ml in PBS; Merck, Darmstadt, Germany) subcutaneously into the plantar side of one hind paw. Eosinophil depletion was achieved by intraperitoneal (i.p.) injection of anti‐Siglec F antibody (0.883 mg/kg; clone 238,047; R&D Systems, Minneapolis, MN) 24 h prior zymosan injection. As control purified rat IgG2a (Biolegend, San Diego, USA) was used. IL‐4c was prepared using IL‐4 (Peprotech, Hamburg, Germany) and anti‐IL4 antibody (Biolegend, San Diego, USA) (Finkelman et al, 1993 (link); Milner et al, 2010 (link); Jenkins et al, 2011 (link)) and administered i.p. (0.166 mg/kg IL‐4 and 0.883 mg/kg anti‐IL4 antibody) 24 h prior zymosan injection. (Finkelman et al, 1993 (link); Milner et al, 2010 (link); Jenkins et al, 2011 (link)).
+ Open protocol
+ Expand
2

Depletion of CD8+ T cells and Eosinophils

Check if the same lab product or an alternative is used in the 5 most similar protocols
To achieve CD8+ T cell depletion, 250 μg of anti-CD8 antibody (clone 2.43; Bio-X-Cell) was intraperitoneally injected into each mouse every 3 days for a total of four injections. InVivoPlus rat isotype antibody (BP0090; Bio-X-Cell) was also injected into mice and used as a control. To achieve eosinophil depletion, 15 μg of anti–Siglec-F antibody (238047; R&D Systems) was intraperitoneally injected into each mouse for four consecutive days. Rat isotype antibody (MAB006; R&D Systems) was also injected into mice and used as a control. To validate the depletion strategy, 100 μg of anti-CCR3 antibody (6S2-19-4; Bio-X-cell) or isotype antibody (BE0090; Bio-X-cell) was injected intraperitoneally.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!